usapep bpc-157 VIAL - High-Purity Peptide for Research BPC-157 — 10 mg -

Select needle gauge/length for comfort and effectiveness

Keep the Conversation Educational, Not Promotional Stick to facts: what we know, what we don't, and what's not approved

FDA investigators said he failed to ensure that all subjects in his clinical trial met eligibility criteria before they were enrolled

Disclosure of interest: KEVIN ROYCE ANG: NOTHING TO DISCLOSE E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P2003 - ESOC25-95 ASSOCIATION OF CTP PARAMETERS WITH OUTCOMES IN PATIENTS WITH MEDIUM VESSEL OCCLUSION UNDERGOING THROMBECTOMY Yoel Schwartzmann 1 , Hamza Joubran 1 , Tamer Jubeh 1 , Issa Metanis 1 , Aviva Alpernas 2 , Tali Jonas Kimchi 2 , Udi Sadeh 2 , John Moshe Gomori 1 , Jose Cohen 1 , Hen Hallevi 2 , Jeremy Molad 2 , Ronen R Leker 1 1 Hadassah-Hebrew University Medical Center, Jerusalem, Israel, 2 Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel Background and Aims: Imaging biomarkers obtained on CT perfusion (CTP) have proven effective in predicting outcomes after EVT in patients with large vessel occlusion stroke